About Betta Pharmaceuticals
Betta Pharmaceuticals is a company based in Hangzhou (China) founded in 2003.. The company has 1,700 employees as of December 31, 2024. Betta Pharmaceuticals operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Hangzhou, China
- Employees 1700 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Betta Pharmaceuticals Co., Ltd. Class A
-
Annual Revenue
$393.18 M (USD)17.55as on Dec 31, 2024
-
Net Profit
$55.15 M (USD)15.67as on Dec 31, 2024
-
EBITDA
$116.18 M (USD)45.45as on Dec 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
1700
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Betta Pharmaceuticals
Betta Pharmaceuticals is a publicly listed company on the SZSE with ticker symbol 300558 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Betta Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2010 | Amount | Series A - Betta Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Betta Pharmaceuticals
Betta Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lilly Asia Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Betta Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Betta Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Betta Pharmaceuticals Comparisons
Competitors of Betta Pharmaceuticals
Betta Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Betta Pharmaceuticals
Frequently Asked Questions about Betta Pharmaceuticals
When was Betta Pharmaceuticals founded?
Betta Pharmaceuticals was founded in 2003 and raised its 1st funding round 7 years after it was founded.
Where is Betta Pharmaceuticals located?
Betta Pharmaceuticals is headquartered in Hangzhou, China. It is registered at Hangzhou, Zhejiang, China.
Who is the current CEO of Betta Pharmaceuticals?
Lieming Ding is the current CEO of Betta Pharmaceuticals.
How many employees does Betta Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at Betta Pharmaceuticals is 1,700.
What is the annual revenue of Betta Pharmaceuticals?
Annual revenue of Betta Pharmaceuticals is $393.18M as on Dec 31, 2024.
What does Betta Pharmaceuticals do?
Founded in 2003 and based in Hangzhou, China, operations focus on the pharmaceutical sector with an emphasis on oncology. Therapeutics targeting cancer are advanced through a pipeline that includes three programs in late-stage clinical development. The lead product, icotinib (Conmana), is utilized as a targeted therapy for non-small cell lung cancer in patients with EGFR mutations.
Who are the top competitors of Betta Pharmaceuticals?
Betta Pharmaceuticals's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Is Betta Pharmaceuticals publicly traded?
Yes, Betta Pharmaceuticals is publicly traded on SZSE under the ticker symbol 300558.
Who are Betta Pharmaceuticals's investors?
Betta Pharmaceuticals has 1 investor. Key investors include Lilly Asia Ventures.
What is Betta Pharmaceuticals's ticker symbol?
The ticker symbol of Betta Pharmaceuticals is 300558 on SZSE.